参考文献/References:
[1] O’Shea JJ,Murray PJ. Cytokine signaling modules in inflammatory responses[J]. Immunity,2008,28(4):477-487.
[2]Verreck FA,de Boer T,Langenberg DM,et al. Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria[J]. Proc Natl Acad Sci U S A,2004,101(13):4560-4565.
[3]Kon V,Linton MF,Fazio S. Atherosclerosis in chronic kidney disease:the role of macrophages[J]. Nat Rev Nephrol,2011,7(1):45-54.
[4]Meng XM,Tang PM,Li J,et al. Macrophage phenotype in kidney injury and repair[J]. Kidney Dis (Basel),2015,1(2):138-146.
[5] Ricardo SD,van Goor H,Eddy AA. Macrophage diversity in renal injury and repair[J]. J CLIN INVEST,2008,118(11):3522-3530.
[6]Liao Y,Li G,Zhang X,et al. Cardiac nestin(+) mesenchymal stromal cells enhance healing of ischemic heart through periostin-mediated M2 macrophage polarization[J]. Mol Ther,2020,28(3):855-873.
[7] Cheng Y,Feng Y,Xia Z,et al. ω-Alkynyl arachidonic acid promotes anti-inflammatory macrophage M2 polarization against acute myocardial infarction via regulating the cross-talk between PKM2 ,HIF-1alpha and iNOS[J]. Biochim Biophys Acta Mol Cell Biol Lipids,2017,1862 (12) :1595-1605.
[8]Tokutome M,Matoba T,Nakano Y,et al. Peroxisome proliferator-activated receptor-gamma targeting nanomedicine promotes cardiac healing after acute myocardial infarction by skewing monocyte/macrophage polarization in preclinical animal models[J]. Cardiovasc Res,2019,115(2):419-431.
[9]Engel JE,Williams E,Williams ML,et al. Targeted VEGF (Vascular Endothelial Growth Factor) therapy induces long-term renal recovery in chronic kidney disease via macrophage polarization[J]. Hypertension,2019,74(5):1113-1123.
[10]Lin Q,Fan C,Skinner JT,et al. RELMα licenses macrophages for damage-associated molecular pattern activation to instigate pulmonary vascular remodeling[J].J Immunol,2019,203 (11):2862-2871.
[11]Xu R,Zhang F,Chai R,et al. Exosomes derived from pro-inflammatory bone marrow-derived mesenchymal stem cells reduce inflammation and myocardial injury via mediating macrophage polarization[J]. J cell Mol Med,2019,23(11):7617-7631.
[12]Deng S,Zhou X,Ge Z,et al. Exosomes from adipose-derived mesenchymal stem cells ameliorate cardiac damage after myocardial infarction by activating S1P/SK1/S1PR1 signaling and promoting macrophage M2 polarization[J]. Int J Biochem Cell Biol,2019,114:105564.
[13] Wang C,Zhang C,Liu L,et al. Macrophage-derived miR-155-containing exosomes suppress fibroblast proliferation and promote fibroblast inflammation during cardiac injury[J]. Mol Ther,2017,25(1):192-204.
[14]Klinger JR,Pereira M,Del TM,et al. Mesenchymal stem cell extracellular vesicles reverse sugen/hypoxia pulmonary hypertension in rats[J]. Am J Respir Cell Mol Biol,2020,62(5):577‐587.
[15] Pan Y,Hui X,Hoo R,et al. Adipocyte-secreted exosomal microRNA-34a inhibits M2 macrophage polarization to promote obesity-induced adipose inflammation[J]. J Clin Invest ,2019,129(2):834-849.
[16]Shah R,Patel T,Freedman JE. Circulating extracellular vesicles in human disease[J]. N Engl J Med,2018,379(10):958-966.
[17]Colombo M,Raposo G,Théry C. Biogenesis,secretion,and intercellular interactions of exosomes and other extracellular vesicles[J]. Annu Rev Cell Dev Biol,2014,30:255-289.
[18]Kalluri R,LeBleu VS. The biology,function,and biomedical applications of exosomes[J]. Science,2020,367(6478):eaau6977.
[19]张?,孙冬冬,范延红. 外泌体在心血管疾病中的作用[J]. 心血管病学进展,2019 ,40(4):618-621.
[20]Patil M,Henderson J,Luong H,et al. The art of intercellular wireless communications :exosomes in heart disease and therapy[J]. Front Cell Dev Biol,2019,7:315.
[21] Zheng B,Yin WN,Suzuki T,et al. Exosome-mediated miR-155 transfer from smooth muscle cells to endothelial cells induces endothelial injury and promotes atherosclerosis[J]. Mol Ther,2017,25(6):1279-1294.
[22]Li H,Liao Y,Gao L,et al. Coronary serum exosomes derived from patients with myocardial ischemia regulate angiogenesis through the miR-939-mediated nitric oxide signaling pathway[J]. Theranostics,2018,8(8):2079-2093.
[23]Gallet R,Dawkins J,Valle J,et al. Exosomes secreted by cardiosphere-derived cells reduce scarring,attenuate adverse remodelling,and improve function in acute and chronic porcine myocardial infarction[J]. Eur Heart J,2017,38(3):201-211.
[24]Chen Q,Liu Y,Ding X,et al. Bone marrow mesenchymal stem cell-secreted exosomes carrying microRNA-125b protect against myocardial ischemia reperfusion injury via targeting SIRT7[J]. Mol Cell Biochem,2020,465(1-2):103-114.
[25]Xiao J,Pan Y,Li XH,et al. Cardiac progenitor cell-derived exosomes prevent cardiomyocytes apoptosis through exosomal miR-21 by targeting PDCD4[J]. Cell Death Dis,2016,7(6):e2277.
[26] Chang YJ,Li YS,Wu CC,et al. Extracellular microRNA-92a mediates endothelial cell-macrophage communication[J]. Arterioscler Thromb Vasc Biol,2019,39(12):2492-2504.
[27]Ouimet M,Ediriweera HN,Gundra UM,et al. MicroRNA-33-dependent regulation of macrophage metabolism directs immune cell polarization in atherosclerosis[J]. J Clin Invest,2015,125(12):4334-4348.
[28]Stamatikos A,Knight E,Vojtech L,et al. Exosome-mediated transfer of anti-miR-33a-5p from transduced endothelial cells enhances macrophage and vascular smooth muscle cell cholesterol efflux[J]. Hum Gene Ther,2020,31(3-4):219‐232.
[29]de Couto G,Gallet R,Cambier L,et al. Exosomal microRNA transfer into macrophages mediates cellular postconditioning[J]. Circulation,2017,136(2):200-214.
[30]Cambier L,de Couto G,Ibrahim A,et al. Y RNA fragment in extracellular vesicles confers cardioprotection via modulation of IL-10 expression and secretion[J]. Embo Mol Med,2017,9(3):337-352.
[31] Cambier L,Giani JF,Liu W,et al. AngiotensinⅡ-induced end-organ damage in mice is attenuated by human exosomes and by an exosomal Y RNA fragment[J]. Hypertension,2018,72(2):370-380.
[32]Zhao J,Li X,Hu J,et al. Mesenchymal stromal cell-derived exosomes attenuate myocardial ischaemia-reperfusion injury through miR-182-regulated macrophage polarization[J]. Cardiovasc Res,2019,115(7):1205-1216.
[33]Li J,Xue H,Li T,et al. Exosomes derived from mesenchymal stem cells attenuate the progression of atherosclerosis in ApoE-/- mice via miR-let7 mediated infiltration and polarization of M2 macrophage [J]. Biochem Biophys Res Commun,2019,510(4):565-572.
[34]Harane NE,Correa BL,Gomez I,et al. Extracellular vesicles from human cardiovascular progenitors trigger a reparative immune response in infarcted hearts[J]. Cardiovasc Res,2020,pii:cvaa028.DOI:10.1093/cvr/cvaa028.
[35]Singla DK,Johnson TA,Tavakoli DZ. Exosome treatment enhances anti-inflammatory M2 macrophages and reduces inflammation-induced pyroptosis in doxorubicin-induced cardiomyopathy[J]. Cells,2019,8(10):1224.
[36] Sun X,Shan A,Wei Z,et al. Intravenous mesenchymal stem cell-derived exosomes ameliorate myocardial inflammation in the dilated cardiomyopathy[J]. Biochem Biophys Res Commun,2018,503(4):2611-2618.
[37]Niu C,Wang X,Zhao M,et al. Macrophage foam cell-derived extracellular vesicles promote vascular smooth muscle cell migration and adhesion[J]. J Am Heart Assoc,2016,5(10):e004099.
[38]Nguyen MA,Karunakaran D,Geoffrion M,et al. Extracellular vesicles secreted by atherogenic macrophages transfer microRNA to inhibit cell migration[J]. Arterioscler Thromb Vasc Biol,2018,38(1):49-63.
[39]Zhu J,Liu B,Wang Z,et al. Exosomes from nicotine-stimulated macrophages accelerate atherosclerosis through miR-21-3p/PTEN-mediated VSMC migration and proliferation[J]. Theranostics,2019,9(23):6901-6919.
[40]Wu G,Zhang J,Zhao Q,et al. Molecularly engineered macrophage-derived exosomes with inflammation tropism and intrinsic heme biosynthesis for atherosclerosis treatment[J]. Angew Chem Int Ed Engl,2020,59(10):4068‐4074.
相似文献/References:
[1]宋菲,综述,俞梦越,等.干细胞来源的外泌体:心肌梗死治疗新启示[J].心血管病学进展,2016,(2):125.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.007]
SONG Fei,YU Mengyue.Exosomes Derived from Stem Cells: Novel Approach in Treatment of
Myocardial Infarction[J].Advances in Cardiovascular Diseases,2016,(8):125.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.007]
[2]姚雯,毛露,孙硕,等.心源性外泌体作为冠心病标志物和新靶点展望[J].心血管病学进展,2019,(6):844.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.002]
YAO Wen,MAO Lu,SUN Shuo,et al.Exogenous Exosome as A New Marker and Target of Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2019,(8):844.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.002]
[3]张维 张恒 康品方.外泌体在心血管疾病中的研究进展[J].心血管病学进展,2019,(5):818.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.038]
Zhang WeiKang Pinfang.Exosome in Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2019,(8):818.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.038]
[4]张伟 黄从新.巨噬细胞与心血管稳态和疾病[J].心血管病学进展,2019,(9):1241.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.014]
ZHANG Wei,HUANG Congxin.Macrophages are Associated with Cardiovascular Homeostasis and Diseases[J].Advances in Cardiovascular Diseases,2019,(8):1241.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.014]
[5]张伟 木胡牙提.外泌体源性miRNAs在心血管疾病中的研究进展[J].心血管病学进展,2020,(2):111.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.002]
Zhang Wei,Muhuyati.Exogenous miRNAs in Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2020,(8):111.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.002]
[6]叶莎 杨翠玲 郑媛媛.骨髓间充质干细胞来源外泌体通过PI3K/Akt途径减轻H2O2诱导心肌细胞损伤[J].心血管病学进展,2022,(3):269.[doi:10.16806/j.cnki.issn.1004-3934.2022.03.000]
YE Sha,YANG Cuiling,ZHENG Yuanyuan.Bone Marrow Mesenchymal Stem Cells Derived Exosomes Attenuate H 2O2 Induced Cardiomyocyte Injury Via PI3K/Akt Pathway[J].Advances in Cardiovascular Diseases,2022,(8):269.[doi:10.16806/j.cnki.issn.1004-3934.2022.03.000]
[7]肖轶 余国龙.不同干细胞来源的外泌体在缺血性心脏病中的促血管新生作用[J].心血管病学进展,2022,(4):293.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.002]
XIAO Yi,YU Guolong?/html>.Application of Exosomes Derived from Various Stem Cells?n Ischemic Heart Disease[J].Advances in Cardiovascular Diseases,2022,(8):293.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.002]
[8]俞佳丽 景雨 张剑 陈楚 陆齐 顾周山 陈子微 周大胜 景宏美 潘丽华.间充质干细胞来源的外泌体在心肌梗死治疗中的研究进展[J].心血管病学进展,2022,(4):341.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.013]
YU JialiJING YuZHANG JianCHEN ChuLU QiGU ZhoushanCHEN ZiweiZHOU DashenJING HongmeiPAN Lihua.Exosomes Derived from Mesenchymal Stem Cells?n the Treatment of Myocardial Infarction[J].Advances in Cardiovascular Diseases,2022,(8):341.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.013]
[9]陈远洋 王志维.供体巨噬细胞在心脏移植中的研究进展[J].心血管病学进展,2022,(6):514.[doi:10.16806/j.cnki.issn.1004-3934.2022.06.009]
CHEN Yuanyang,WANG Zhiwei.Donor Macrophages in Heart Transplantation[J].Advances in Cardiovascular Diseases,2022,(8):514.[doi:10.16806/j.cnki.issn.1004-3934.2022.06.009]
[10]付韫韬 赵庆彦?/html>.巨噬细胞调控离子通道致心律失常研究的最新进展[J].心血管病学进展,2022,(2):100.[doi:10.16806/j.cnki.issn.1004-3934.2022.02.002]
FU Yuntao ZHAO Qingyan.Macrophages Regulating Ion Channels to Induce Arrhythmia[J].Advances in Cardiovascular Diseases,2022,(8):100.[doi:10.16806/j.cnki.issn.1004-3934.2022.02.002]